FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7630211000001106: Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20534901000001110 Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
20535001000001110 Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Is a Product containing precisely simvastatin 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Has excipient Butylated hydroxyanisole false Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Simvastatin false Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Is a Ranzolont true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Has specific active ingredient Simvastatin true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) 28 tablet 2 x 14 tablets Is pack of False Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier
Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP True Ranzolont 10mg tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start